127 related articles for article (PubMed ID: 25669040)
21. [From JSLH (The Japanese Society for Laboratory Hematology): An Active Team Approach to Medicine as Laboratory Technologists, through Showing Bone Marrow and Peripheral Blood Samples Directly to Patients with Hematological Malignancy].
Shimizu S; Kojima Y; Saito K; Wada H; Yamamoto M; Morinaga K; Kawai Y; Haba T
Rinsho Byori; 2014 Nov; 62(11):1143-50. PubMed ID: 27509737
[TBL] [Abstract][Full Text] [Related]
22. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
[TBL] [Abstract][Full Text] [Related]
23. Patterns of hematological malignancies in Chernobyl clean-up workers (1996-2005).
Gluzman D; Imamura N; Sklyarenko L; Nadgornaya V; Zavelevich M; Machilo V
Exp Oncol; 2006 Mar; 28(1):60-3. PubMed ID: 16614710
[TBL] [Abstract][Full Text] [Related]
24. Myelodysplastic syndromes: the pediatric point of view.
Locatelli F; Zecca M; Pession A; Maserati E; De Stefano P; Severi F
Haematologica; 1995; 80(3):268-79. PubMed ID: 7672722
[TBL] [Abstract][Full Text] [Related]
25. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
[TBL] [Abstract][Full Text] [Related]
26. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
[TBL] [Abstract][Full Text] [Related]
27. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
Sobecks RM; Le Beau MM; Anastasi J; Williams SF
Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
[TBL] [Abstract][Full Text] [Related]
28. [Morphology and immunophenotyping in hematological malignancies].
Kawai Y; Shimizu N; Ujiie M; Takeshita E; Todoroki T; Mitsuhashi T; Watanabe K
Rinsho Byori; 2000 Aug; 48(8):694-701. PubMed ID: 11064591
[TBL] [Abstract][Full Text] [Related]
29. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z; Sandberg AA
Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
[TBL] [Abstract][Full Text] [Related]
30. Non-AIDS-defining hematological malignancies in HIV-infected patients: an epidemiological study in Japan.
Hagiwara S; Yotsumoto M; Odawara T; Ajisawa A; Uehira T; Nagai H; Tanuma J; Okada S
AIDS; 2013 Jan; 27(2):279-83. PubMed ID: 23014520
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetics in the diagnosis of hematologic malignancies.
Clare N; Hansen K
Hematol Oncol Clin North Am; 1994 Aug; 8(4):785-807. PubMed ID: 7961291
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.
Ohgami RS; Chisholm KM; Ma L; Arber DA
Am J Clin Pathol; 2014 May; 141(5):656-64. PubMed ID: 24713736
[TBL] [Abstract][Full Text] [Related]
33. Peripheral blood cytogenetic studies in hematological neoplasms: predictors of obtaining metaphases for analysis.
Hussein K; Ketterling RP; Hulshizer RL; Kuffel DG; Wiktor AE; Hanson CA; Tefferi A; Van Dyke DL
Eur J Haematol; 2008 Apr; 80(4):318-21. PubMed ID: 18088399
[TBL] [Abstract][Full Text] [Related]
34. Spectrum of hematological malignancies and peripheral cytopenias.
Jha A
J Nepal Health Res Counc; 2013 Sep; 11(25):273-8. PubMed ID: 24908530
[TBL] [Abstract][Full Text] [Related]
35. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
Mufti GJ; Bennett JM; Goasguen J; Bain BJ; Baumann I; Brunning R; Cazzola M; Fenaux P; Germing U; Hellström-Lindberg E; Jinnai I; Manabe A; Matsuda A; Niemeyer CM; Sanz G; Tomonaga M; Vallespi T; Yoshimi A;
Haematologica; 2008 Nov; 93(11):1712-7. PubMed ID: 18838480
[TBL] [Abstract][Full Text] [Related]
37. [What Should We Do in the Department of Clinical Laboratory in the Future?--Chairmen's Introductory Remarks].
Matsumoto H; Murata M
Rinsho Byori; 2014 Oct; 62(10):986-7. PubMed ID: 27526545
[TBL] [Abstract][Full Text] [Related]
38. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
39. [Required education for medical technologists of the next generation--chairmen's introductory remarks].
Mimura K; Hosoi E
Rinsho Byori; 2014 May; 62(5):478-80. PubMed ID: 25051663
[TBL] [Abstract][Full Text] [Related]
40. Replication errors in hematological neoplasias: genomic instability in progression of disease is different among different types of leukemia.
Ohyashiki JH; Ohyashiki K; Aizawa S; Kawakubo K; Shimamoto T; Iwama H; Hayashi S; Toyama K
Clin Cancer Res; 1996 Sep; 2(9):1583-9. PubMed ID: 9816337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
